Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Empagliflozin 10 MG OD
DRUG
2 trials
Sponsors
Instituto Nacional de Cardiologia Ignacio Chavez
, Fatima Maqsood
Conditions
Congenital Heart Disease
Diabetes Mellitus
Heart Failure
Heart Failure With Reduced Ejection Fraction
Phase 2
Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD
NCT05580510
Instituto Nacional de Cardiologia Ignacio Chavez
Congenital Heart Disease, Heart Failure, Heart Failure With Reduced Ejection Fraction
Start: 2023-02-06
End: 2024-03-29
Target: 160
Updated: 2022-11-02
Unknown Phase
Comparison of Empagliflozin and Dapagliflozin in Patients With Heart Failure Taking Standard Treatment
Completed
NCT06915870
Fatima Maqsood
Diabetes Mellitus, Heart Failure
Start: 2024-07-12
End: 2025-01-13
Updated: 2025-04-08
Related Papers
Rationale and design of Dapagliflozin vErsus SacubiTrIl-valsartaN therapY in Heart Failure with reduced ejection fraction (DESTINY-HF): a pragmatic randomised controlled trial protocol
BMJ Open
2024-10-01
1 citations